These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 28939985)
1. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription. Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985 [TBL] [Abstract][Full Text] [Related]
2. Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells. Xie JJ; Xu LY; Xie YM; Zhang HH; Cai WJ; Zhou F; Shen ZY; Li EM Int J Cancer; 2009 Jun; 124(11):2549-58. PubMed ID: 19165868 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA ATB promotes malignancy of esophageal squamous cell carcinoma by regulating miR-200b/Kindlin-2 axis. Li Z; Wu X; Gu L; Shen Q; Luo W; Deng C; Zhou Q; Chen X; Li Y; Lim Z; Wang X; Wang J; Yang X Cell Death Dis; 2017 Jun; 8(6):e2888. PubMed ID: 28640252 [TBL] [Abstract][Full Text] [Related]
4. Ezrin Ser66 phosphorylation regulates invasion and metastasis of esophageal squamous cell carcinoma cells by mediating filopodia formation. Li LY; Xie YH; Xie YM; Liao LD; Xu XE; Zhang Q; Zeng FM; Tao LH; Xie WM; Xie JJ; Xu LY; Li EM Int J Biochem Cell Biol; 2017 Jul; 88():162-171. PubMed ID: 28504189 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1. Wu D; He X; Wang W; Hu X; Wang K; Wang M Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639 [TBL] [Abstract][Full Text] [Related]
6. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma. Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013 [TBL] [Abstract][Full Text] [Related]
7. miR‑378a‑3p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10. Ding N; Sun X; Wang T; Huang L; Wen J; Zhou Y Int J Mol Med; 2018 Jul; 42(1):381-391. PubMed ID: 29693138 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis. Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022 [TBL] [Abstract][Full Text] [Related]
9. STK3 kinase activation inhibits tumor proliferation through FOXO1-TP53INP1/P21 pathway in esophageal squamous cell carcinoma. Zhao Z; Chu Y; Feng A; Zhang S; Wu H; Li Z; Sun M; Zhang L; Chen T; Xu M Cell Oncol (Dordr); 2024 Aug; 47(4):1295-1314. PubMed ID: 38436783 [TBL] [Abstract][Full Text] [Related]
10. Silencing of Rab3D suppresses the proliferation and invasion of esophageal squamous cell carcinoma cells. Zhang J; Kong R; Sun L Biomed Pharmacother; 2017 Jul; 91():402-407. PubMed ID: 28472755 [TBL] [Abstract][Full Text] [Related]
11. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma. Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580 [TBL] [Abstract][Full Text] [Related]
12. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression. Tang M; Zhao S; Ren L; Li Q; Li L; Wang C; Meng C; Chen Y; Hu W Front Biosci (Landmark Ed); 2024 Apr; 29(4):138. PubMed ID: 38682192 [TBL] [Abstract][Full Text] [Related]
13. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma. Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144 [TBL] [Abstract][Full Text] [Related]
14. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis. Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896 [TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA GK-IT1 promotes esophageal squamous cell carcinoma by regulating MAPK1 phosphorylation. Yang X; Zeng T; Liu Z; He W; Hu M; Tang T; Chen L; Xing L Cancer Med; 2022 Dec; 11(23):4555-4574. PubMed ID: 35608100 [TBL] [Abstract][Full Text] [Related]
17. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma. Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393 [TBL] [Abstract][Full Text] [Related]
18. Expression and role of anion exchanger 1 in esophageal squamous cell carcinoma. Shiozaki A; Kudou M; Ichikawa D; Shimizu H; Arita T; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Kishimoto M; Marunaka Y; Otsuji E Oncotarget; 2017 Mar; 8(11):17921-17935. PubMed ID: 28160546 [TBL] [Abstract][Full Text] [Related]
19. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling. Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239 [TBL] [Abstract][Full Text] [Related]
20. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation. Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]